CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Wealth building investment strategies can empower beginners to grow their finances. Explore effective approaches to start investing wisely.
21,485 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Curve rolls out Llamalend v2 on Optimism, expanding collateral and borrowing options. The upgrade comes with a 250,00...
Markets brace for Kevin Warsh’s first policy meeting as chair, with expectations for a steady rate path and close att...
An AI model branded as WarrenAI outlines a bifurcated Bitcoin path for late 2026: a resilient floor around $50k-$55k ...
As markets swing and tax rules shift, households with a $450K+ 401K are weighing year-end charity moves. A Donor-Advi...
Amazon’s Q1 2026 results show AWS posting rapid growth amid a surge in AI demand. With AI revenue above $15B and a $2...
A forum proposal from the founder of Kleros would allow Ethereum validators to redirect up to 10% of staking rewards ...
Lennar's latest results reveal a pricing move not seen in years. This article breaks down why lennar hasn't sold home...
Investors are asking if one AI leader can justify a multibillion-dollar market cap shift. This guide breaks down what...
Comcast plans to divide into two publicly traded entities, creating separate growth stories for NBCUniversal and the ...
A sobering look at how forged credentials can unlock access to your money. This guide shows how it happens, the costs...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...